COVID-19 Project Team: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 50: | Line 50: | ||
'''Gastrointestinal disorders and COVID-19''' | '''Gastrointestinal disorders and COVID-19''' | ||
*'''[[User:Farima Kahe|Farima Kahe, M.D.]]''' | *'''[[User:Farima Kahe|Farima Kahe, M.D.]]''' | ||
*[[User:Javaria Anwer|Javaria Anwer, M.B.B.S.]] | |||
*[[User:TayyabaAli|Tayyaba Ali, M.D.]] | *[[User:TayyabaAli|Tayyaba Ali, M.D.]] | ||
* [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]] | * [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]] |
Revision as of 21:38, 12 August 2020
COVID-19 Project |
---|
Introduction |
Team |
Meetings' Summary |
Topics |
Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]